Champions Oncology CSBR is gearing up to announce its quarterly earnings on Wednesday, 2024-12-11. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Champions Oncology will report an earnings per share (EPS) of $0.01.
Anticipation surrounds Champions Oncology's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
Last quarter the company beat EPS by $0.14, which was followed by a 9.58% increase in the share price the next day.
Here's a look at Champions Oncology's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.16 | -0.15 | -0.17 |
| EPS Actual | 0.11 | 0.01 | -0.16 | -0.15 |
| Price Change % | 10.0% | 3.0% | -3.0% | 5.0% |
Champions Oncology Share Price Analysis
Shares of Champions Oncology were trading at $4.88 as of December 03. Over the last 52-week period, shares are up 0.41%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Champions Oncology visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
